文献速递神经创伤神经重症

颅骨修补术后再手术风险因素分析

Reoperation Risk Factors for Cranioplasty Surgery.
PubMed 文献 · Neurosurgery · 2026-02-27

该单中心回顾性研究纳入318例颅骨修补患者,19.4%需再手术。再手术组去骨瓣减压至修补间隔更短、住院期间修补比例更高、抗血小板/抗凝重启更晚、术前脑室腹腔分流更多、自体骨植入更少。多因素分析显示自体骨植入和术后帽状腱膜下引流与再手术风险降低相关,术后CT积液增多与风险升高相关。

要点

  • 自体骨植入与术后帽状腱膜下引流与再手术风险降低独立相关。
  • 术后CT显示积液增多与再手术风险升高独立相关。
  • 去骨瓣减压至颅骨修补间隔较短者再手术比例更高,需关注手术时机。

核心结论

  • 自体骨植入、术后帽状腱膜下引流和术后CT积液是颅骨修补术后再手术的独立预测因素。

研究设计与样本

  • 单中心回顾性分析纳入318例颅骨修补患者,排除既往颅骨修补或去骨瓣减压时骨瓣复位者。
  • 收集临床人口学、术前和围手术期参数及术后结局,行单变量和多变量逻辑回归分析。

主要发现

  • 318例中62例(19.4%)需要再手术。
  • 再手术组去骨瓣减压至颅骨修补间隔中位86天(IQR 31-164),非再手术组140天(IQR 79-211),P ≤ .01。
  • 再手术组住院期间行颅骨修补比例21.3% vs 10.9%,P = .03。
  • 再手术组重启抗血小板或抗凝中位时间34天(IQR 18-102),非再手术组11天(IQR 7-16),P = .03。
  • 再手术组术前脑室腹腔分流比例26.2% vs 12.9%,P = .01;自体骨植入比例62.3% vs 80.0%,P ≤ .01。

临床怎么用

  • 颅骨修补时优先考虑自体骨植入可能降低再手术风险。
  • 术后放置帽状腱膜下引流可能降低再手术风险。
  • 术后CT发现积液增多时应警惕再手术风险升高。

局限性

  • 单中心回顾性设计,结果外推需谨慎。
  • 样本量318例,可能影响统计效能。
  • 未报告多变量模型的具体校正变量和模型拟合信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Adverse events after cranioplasty remain a significant burden in postsurgical care, often necessitating reoperations. Identifying predictors of reoperation could optimize care. We investigated reoperation after cranioplasty and factors that correlate. METHODS: A retrospective analysis of 318 cranioplasty patients at our single institution was conducted. Clinical demographics, preoperative and perioperative parameters, and postoperative outcomes of patients were collected from electronic health records. Univariable and multivariable logistic regression were conducted to identify significant predictors of reoperation after cranioplasty. Patients who had previous cranioplasties or the bone flap replaced during the craniectomy were excluded. RESULTS: Of 318 cranioplasty patients, 62 (19.4%) required reoperation. These patients had shorter time intervals between craniectomy and cranioplasty relative to patients who did not require reoperation (median of 86 vs 140 days, IQR: 31-164 and 79-211, P ≤ .01). The reoperation group also had a greater frequency of cranioplasties done during their index hemicraniectomy hospital stay (21.3% vs 10.9%, P = .03), longer time interval to restarting antiplatelets or anticoagulants (median of 34 vs 11 days, IQR 18-102 and 7-16, P = .03), greater number of preoperative ventriculoperitoneal shunt patients (26.2% vs 12.9%, P = .01), and lower utilization of autologous bone implant (62.3% vs 80.0%, P ≤ .01). On multivariable analysis, use of autologous bone implant (odds ratio: 0.38 [0.15-0.94], P = .03) and postoperative subgaleal drain use (odds ratio: 0.35 [0.13-0.91], P = .03) were associated with a lower odds of reoperation, while greater fluid collection on postoperative computed tomography was linked to a higher odds of reoperation (odds ratio: 1.05 [1.01-1.11], P = .02). CONCLUSION: Autologous bone implant, postoperative subgaleal drain use, and fluid collection on postoperative computed tomography are independent predictors of reoperations after cranioplasty. Further assessment of these factors may be beneficial for predictive modeling and surgical management of patients requiring cranioplasty.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Hafazalla K, Carreras A, Filo J, et al. Reoperation Risk Factors for Cranioplasty Surgery. Neurosurgery. 2026. PMID: 41757892. doi:10.1227/neu.0000000000003976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。